No connection

Search Results

BMEZ vs GAM

BMEZ
BlackRock Health Sciences Term Trust
BEARISH
Price
$15.54
Market Cap
$1.57B
Sector
Financial Services
AI Confidence
85%
GAM
General American Investors Company, Inc.
BULLISH
Price
$65.10
Market Cap
$1.56B
Sector
Financial Services
AI Confidence
75%

Valuation

P/E Ratio
BMEZ
--
GAM
4.47
Forward P/E
BMEZ
--
GAM
--
P/B Ratio
BMEZ
--
GAM
1.0
P/S Ratio
BMEZ
--
GAM
64.24
EV/EBITDA
BMEZ
--
GAM
203.08

Profitability

Gross Margin
BMEZ
0.0%
GAM
100.0%
Operating Margin
BMEZ
0.0%
GAM
22.05%
Profit Margin
BMEZ
0.0%
GAM
1398.14%
ROE
BMEZ
--
GAM
20.58%
ROA
BMEZ
--
GAM
0.32%

Growth

Revenue Growth
BMEZ
--
GAM
-22.1%
Earnings Growth
BMEZ
--
GAM
292.3%

Financial Health

Debt/Equity
BMEZ
--
GAM
0.0
Current Ratio
BMEZ
--
GAM
0.86
Quick Ratio
BMEZ
--
GAM
0.49

Dividends

Dividend Yield
BMEZ
8.49%
GAM
0.79%
Payout Ratio
BMEZ
846.82%
GAM
0.0%

AI Verdict

BMEZ BEARISH

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 1/9, indicating weak fundamental strength. The absence of an Altman Z-Score and all profitability metrics at 0.00% suggest opaque or non-existent earnings power and potential structural risks. Despite a high dividend yield of 8.49%, the unsustainable 846.82% payout ratio and bearish insider activity raise red flags. Combined with negative long-term price performance and lack of analyst coverage, the investment case lacks foundational support.

Strengths
High current dividend yield of 8.49% provides income appeal
Recent short-term price momentum: +16.6% over 6 months
Market cap of $1.57B indicates moderate size and potential liquidity
Risks
Piotroski F-Score of 1/9 signals severe financial weakness
Profit margins at 0.00% across all levels (gross, operating, net)
Extremely high payout ratio (846.82%) threatens dividend sustainability
GAM BULLISH

GAM presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 5/9 and a significant discount to its Graham Number ($146.15) and Intrinsic Value ($429.52). While the technical trend is currently bearish (10/100) and revenue growth is negative, the company maintains a fortress balance sheet with zero debt and a strong ROE of 20.58%. The extreme P/E compression (4.47) relative to the sector average (38.56) suggests the market is severely underpricing the company's earnings power. The bullish outlook is driven by fundamental undervaluation and strong historical price performance, despite short-term technical headwinds.

Strengths
Extreme valuation discount with P/E of 4.47 vs sector average of 38.56
Pristine balance sheet with 0.00 Debt/Equity ratio
Strong profitability with ROE at 20.58%
Risks
Negative year-over-year revenue growth (-22.10%)
Very weak technical trend (10/100) indicating short-term bearish momentum
Low dividend yield (0.79%) providing little income support

Compare Another Pair

BMEZ vs GAM: Head-to-Head Comparison

This page compares BlackRock Health Sciences Term Trust (BMEZ) and General American Investors Company, Inc. (GAM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile